Über das Unternehmen
- Firmenname (rechtlich): BLIS Technologies Ltd
- Registrierungsland: New Zealand
- Adresse: 10, Birch St,Dunedin,PO Box No 2208,, Dunedin
- Anzahl der Mitarbeiter: 25 - 49
Beschreibung:
Founded on the research of Professor John Tagg at the University of Otago, New Zealand, and the discovery of oral probiotic strains BLIS K12 and BLIS M18, BLIS Technologies' strains are backed by more than 30 years of research, over 70 clinical trials and an IP-protected supply chain. The company offers partners both ingredient and finished products across health areas including immunity, teeth and gums, mouth, throat and oral health.
Geschäftsaktivitäten
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
Hersteller
Original-Wirkstoffe
Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
Hauptprodukte/-dienstleistungen
Unsere Produkte & Dienstleistungen
Certifications
ISO
Proofs
CPHI Korea 2026
08/2026 – 08/2026
CPHI Korea 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen